Dementia Big
Pfizer has announced that it will be ending its neuroscience discovery and early development efforts, an area which includes research into drug development for Alzheimer’s disease.
http://ift.tt/2AI3oWv
Monday, January 8, 2018
Pfizer ends neuroscience discovery programme, including research into Alzheimer’s disease treatment – Alzheimer’s Society comment
Pfizer ends neuroscience discovery programme, including research into Alzheimer’s disease treatment – Alzheimer’s Society comment:
http://ift.tt/2AI3oWv
http://ift.tt/2AI3oWv
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment